File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Antiretroviral treatment can affect the release of NO and EDCF, but EDH in rat arteries

TitleAntiretroviral treatment can affect the release of NO and EDCF, but EDH in rat arteries
Authors
KeywordsMedical sciences
Cardiovascular diseases
Issue Date2012
PublisherS Karger AG. The Journal's web site is located at http://www.karger.com/JVR
Citation
The 10th Anniversary EDHF Meeting (EDHF 2012), Vaux-de-Cernay, France, 27-30 June 2012. In Journal of Vascular Research, 2012, v. 49 suppl. 2, abstract no. 37 How to Cite?
AbstractDespite improving clinical outcomes, highly active antiretroviral therapy (HAART) is an independent potential risk factor for cardiovascular diseases. Currently the recommended HAART regimen commonly comprises a protease inhibitor (PI) with ritonavir (RTV)-boosting or a nonnucleoside reverse transcriptase inhibitor (NNRTI), and two nucleoside reverse transcriptase inhibitors. The present study examined whether or not boosted lopin...
DescriptionThis journal suppl. entitled: EDHF 2012 - 10th Anniversary Meeting
Persistent Identifierhttp://hdl.handle.net/10722/165630
ISSN
2015 Impact Factor: 2.186
2015 SCImago Journal Rankings: 1.119

 

DC FieldValueLanguage
dc.contributor.authorNejad, Aen_US
dc.contributor.authorLee, SSen_US
dc.contributor.authorVanhoutte, PMen_US
dc.contributor.authorLeung, SWSen_US
dc.date.accessioned2012-09-20T08:21:22Z-
dc.date.available2012-09-20T08:21:22Z-
dc.date.issued2012en_US
dc.identifier.citationThe 10th Anniversary EDHF Meeting (EDHF 2012), Vaux-de-Cernay, France, 27-30 June 2012. In Journal of Vascular Research, 2012, v. 49 suppl. 2, abstract no. 37en_US
dc.identifier.issn1018-1172-
dc.identifier.urihttp://hdl.handle.net/10722/165630-
dc.descriptionThis journal suppl. entitled: EDHF 2012 - 10th Anniversary Meeting-
dc.description.abstractDespite improving clinical outcomes, highly active antiretroviral therapy (HAART) is an independent potential risk factor for cardiovascular diseases. Currently the recommended HAART regimen commonly comprises a protease inhibitor (PI) with ritonavir (RTV)-boosting or a nonnucleoside reverse transcriptase inhibitor (NNRTI), and two nucleoside reverse transcriptase inhibitors. The present study examined whether or not boosted lopin...-
dc.languageengen_US
dc.publisherS Karger AG. The Journal's web site is located at http://www.karger.com/JVR-
dc.relation.ispartofJournal of Vascular Researchen_US
dc.rightsJournal of Vascular Research. Copyright © S Karger AG.-
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License-
dc.subjectMedical sciences-
dc.subjectCardiovascular diseases-
dc.titleAntiretroviral treatment can affect the release of NO and EDCF, but EDH in rat arteriesen_US
dc.typeConference_Paperen_US
dc.identifier.emailVanhoutte, PM: vanhoutt@hku.hken_US
dc.identifier.emailLeung, SWS: swsleung@hku.hken_US
dc.identifier.authorityVanhoutte, PM=rp00238en_US
dc.identifier.authorityLeung, SWS=rp00235en_US
dc.description.naturepostprint-
dc.identifier.doi10.1159/000339218-
dc.identifier.hkuros211038en_US
dc.identifier.volume49-
dc.identifier.issuesuppl. 2-
dc.publisher.placeSwitzerland-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats